Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients

To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general ane...

Full description

Saved in:
Bibliographic Details
Published inBreast (Edinburgh) Vol. 18; no. 2; pp. 130 - 134
Main Authors Imoto, Shigeru, Wada, Noriaki, Sakemura, Noriko, Hasebe, Takahiro, Murata, Yukinori
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.04.2009
Subjects
Online AccessGet full text
ISSN0960-9776
1532-3080
1532-3080
DOI10.1016/j.breast.2009.02.008

Cover

Abstract To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general anesthesia, sentinel node biopsy was performed, followed by RFA and BCS. Resected specimens were examined at 5-mm intervals by hematoxylin–eosin (H&E) staining and nicotinamide adenine dinucleotide (NADH) diaphorase staining. Thirty of the 34 eligible patients were enrolled. RFA-related adverse events were observed in nine patients: two with skin burn and seven with muscle burn. Twenty-six patients (87%) showed pathological degenerative changes in tumor specimens with H&E staining. In 24 of the 26 cases (92%) examined by NADH diaphorase staining, tumor cell viability was diagnosed as negative. RFA proved to be reliable and feasible in clinical stage I breast cancer, with no extensive intraductal components. Randomized clinical trials are needed to compare RFA with BCS.
AbstractList To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general anesthesia, sentinel node biopsy was performed, followed by RFA and BCS. Resected specimens were examined at 5-mm intervals by hematoxylin-eosin (H&E) staining and nicotinamide adenine dinucleotide (NADH) diaphorase staining. Thirty of the 34 eligible patients were enrolled. RFA-related adverse events were observed in nine patients: two with skin burn and seven with muscle burn. Twenty-six patients (87%) showed pathological degenerative changes in tumor specimens with H&E staining. In 24 of the 26 cases (92%) examined by NADH diaphorase staining, tumor cell viability was diagnosed as negative. RFA proved to be reliable and feasible in clinical stage I breast cancer, with no extensive intraductal components. Randomized clinical trials are needed to compare RFA with BCS.
To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general anesthesia, sentinel node biopsy was performed, followed by RFA and BCS. Resected specimens were examined at 5-mm intervals by hematoxylin-eosin (H&E) staining and nicotinamide adenine dinucleotide (NADH) diaphorase staining. Thirty of the 34 eligible patients were enrolled. RFA-related adverse events were observed in nine patients: two with skin burn and seven with muscle burn. Twenty-six patients (87%) showed pathological degenerative changes in tumor specimens with H&E staining. In 24 of the 26 cases (92%) examined by NADH diaphorase staining, tumor cell viability was diagnosed as negative. RFA proved to be reliable and feasible in clinical stage I breast cancer, with no extensive intraductal components. Randomized clinical trials are needed to compare RFA with BCS.To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general anesthesia, sentinel node biopsy was performed, followed by RFA and BCS. Resected specimens were examined at 5-mm intervals by hematoxylin-eosin (H&E) staining and nicotinamide adenine dinucleotide (NADH) diaphorase staining. Thirty of the 34 eligible patients were enrolled. RFA-related adverse events were observed in nine patients: two with skin burn and seven with muscle burn. Twenty-six patients (87%) showed pathological degenerative changes in tumor specimens with H&E staining. In 24 of the 26 cases (92%) examined by NADH diaphorase staining, tumor cell viability was diagnosed as negative. RFA proved to be reliable and feasible in clinical stage I breast cancer, with no extensive intraductal components. Randomized clinical trials are needed to compare RFA with BCS.
Abstract To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for clinical stage I breast cancer patients. Subjects were T1N0 breast cancer patients with no extensive intraductal components. Under general anesthesia, sentinel node biopsy was performed, followed by RFA and BCS. Resected specimens were examined at 5-mm intervals by hematoxylin–eosin (H&E) staining and nicotinamide adenine dinucleotide (NADH) diaphorase staining. Thirty of the 34 eligible patients were enrolled. RFA-related adverse events were observed in nine patients: two with skin burn and seven with muscle burn. Twenty-six patients (87%) showed pathological degenerative changes in tumor specimens with H&E staining. In 24 of the 26 cases (92%) examined by NADH diaphorase staining, tumor cell viability was diagnosed as negative. RFA proved to be reliable and feasible in clinical stage I breast cancer, with no extensive intraductal components. Randomized clinical trials are needed to compare RFA with BCS.
Author Hasebe, Takahiro
Murata, Yukinori
Sakemura, Noriko
Wada, Noriaki
Imoto, Shigeru
Author_xml – sequence: 1
  givenname: Shigeru
  surname: Imoto
  fullname: Imoto, Shigeru
  email: imoto@kyorin-u.ac.jp
  organization: Department of Breast Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
– sequence: 2
  givenname: Noriaki
  surname: Wada
  fullname: Wada, Noriaki
  organization: Division of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan
– sequence: 3
  givenname: Noriko
  surname: Sakemura
  fullname: Sakemura, Noriko
  organization: Department of Breast Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
– sequence: 4
  givenname: Takahiro
  surname: Hasebe
  fullname: Hasebe, Takahiro
  organization: Office for Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Chuoku, Tokyo 104-0045, Japan
– sequence: 5
  givenname: Yukinori
  surname: Murata
  fullname: Murata, Yukinori
  organization: Pathology Section, Clinical Laboratory Division, Kohnodai Hospital, International Medical Center of Japan, Ichikawa, Chiba 272-8516, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19324550$$D View this record in MEDLINE/PubMed
BookMark eNqVkluL1TAUhYOMOGdG_4FInnxrzaXpRUSQwdGBAR_U55Amu5JjmhyTVOm_N7UjgiCDT4HkWyt7r70v0JkPHhB6SklNCW1fHOsxgkq5ZoQMNWE1If0DdKCCs4qTnpyhAxlaUg1d156ji5SOpIC87R-hczpw1ghBDshfFw87WmfzilNezIqDx1EZG6YI3xbwesVqdCrbcj8F58IPMHhc8UnFbJXDc6kBdA7zWp5j8VBfAN_gvTisldcQC5wt-Jweo4eTcgme3J2X6PP1209X76vbD-9urt7cVlrwJlfAOiZ6DqzhtGvINDUKVM9GQYXpDCO87w3oRkx6asdWNF0zDr1WZtS6I_1k-CV6vvueYihNpCxnmzQ4pzyEJcm2o4JRMRTw2R24jDMYeYp2VnGVvxMqQLMDOoaUIkx_ECK3Qcij3HuV2yAkYbIMoshe_iXTNv8KMUdl3X3i17sYSkTfLUSZdIlPg7GxRC1NsP9roJ31Viv3FVZIx7BEX-KXVKYikB-3Rdn2hAxlRzjbun71b4P7__8J6i3RyQ
CitedBy_id crossref_primary_10_7759_cureus_56653
crossref_primary_10_1016_j_ejso_2012_08_006
crossref_primary_10_1007_s12282_010_0197_6
crossref_primary_10_1177_15330338231157193
crossref_primary_10_2214_AJR_10_5581
crossref_primary_10_1007_s12282_024_01584_4
crossref_primary_10_1016_j_clbc_2014_02_002
crossref_primary_10_1111_his_12926
crossref_primary_10_2214_AJR_16_17129
crossref_primary_10_1007_s00268_012_1820_9
crossref_primary_10_1016_j_breast_2010_01_016
crossref_primary_10_1007_s00432_010_0808_9
crossref_primary_10_1016_j_soc_2010_11_003
crossref_primary_10_1556_OH_2014_29783
crossref_primary_10_7314_APJCP_2012_13_2_737
crossref_primary_10_1016_j_ejso_2010_09_012
crossref_primary_10_1007_s10147_019_01423_z
crossref_primary_10_1016_j_soc_2014_03_009
crossref_primary_10_1016_j_ejso_2014_07_031
crossref_primary_10_1016_j_clbc_2017_09_007
crossref_primary_10_1016_j_breast_2011_04_007
crossref_primary_10_1016_S2173_5107_11_70012_X
crossref_primary_10_1007_s00330_016_4668_9
crossref_primary_10_1007_s12282_010_0222_9
crossref_primary_10_1016_S1470_2045_23_00615_0
crossref_primary_10_1016_j_ejso_2013_09_007
crossref_primary_10_1080_02656736_2016_1230232
crossref_primary_10_1016_j_senol_2015_01_006
crossref_primary_10_3109_02656736_2014_914250
crossref_primary_10_3109_10520295_2010_517473
crossref_primary_10_1016_j_breast_2012_11_004
crossref_primary_10_1016_j_rx_2010_12_005
crossref_primary_10_1007_s11912_022_01290_4
Cites_doi 10.1056/NEJMoa022152
10.1002/jso.20398
10.1158/1078-0432.CCR-06-1345
10.1016/S0002-9610(02)00942-X
10.1001/archsurg.141.2.181
10.1245/s10434-008-9875-4
10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W
10.1245/ASO.2004.08.003
10.1200/JCO.2004.03.097
10.1245/s10434-006-9315-2
10.1001/archsurg.134.10.1064
10.1148/radiol.2281012163
10.1016/S1072-7515(01)00798-0
10.1200/JCO.2007.15.0235
10.1007/BF02967618
10.1016/S0002-9610(03)00061-8
10.1016/j.ejso.2005.08.010
10.1016/S0140-6736(05)66544-0
10.1056/NEJMoa020989
10.1200/JCO.2007.14.4667
10.1016/S0140-6736(00)02654-4
10.1002/cncr.11642
ContentType Journal Article
Copyright 2009 Elsevier Ltd
Elsevier Ltd
Copyright_xml – notice: 2009 Elsevier Ltd
– notice: Elsevier Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.breast.2009.02.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-3080
EndPage 134
ExternalDocumentID 19324550
10_1016_j_breast_2009_02_008
S0960977609000320
1_s2_0_S0960977609000320
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HEC
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
L7B
M29
M2X
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OK1
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPM
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SSH
SSZ
T5K
WUQ
Z5R
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
NCXOZ
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c534t-e272583e2431740ff4aea82b515d7d20388dec45fcf6b65474b98cadbcc708fd3
IEDL.DBID .~1
ISSN 0960-9776
1532-3080
IngestDate Fri Sep 05 08:13:27 EDT 2025
Mon Jul 21 05:58:51 EDT 2025
Tue Jul 01 03:58:43 EDT 2025
Thu Apr 24 22:55:58 EDT 2025
Fri Feb 23 02:27:22 EST 2024
Sun Feb 23 10:19:36 EST 2025
Tue Aug 26 16:33:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Radiofrequency ablation
Breast cancer
Intraductal components
Breast-conserving surgery
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-e272583e2431740ff4aea82b515d7d20388dec45fcf6b65474b98cadbcc708fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19324550
PQID 67152159
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_67152159
pubmed_primary_19324550
crossref_primary_10_1016_j_breast_2009_02_008
crossref_citationtrail_10_1016_j_breast_2009_02_008
elsevier_sciencedirect_doi_10_1016_j_breast_2009_02_008
elsevier_clinicalkeyesjournals_1_s2_0_S0960977609000320
elsevier_clinicalkey_doi_10_1016_j_breast_2009_02_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-04-01
PublicationDateYYYYMMDD 2009-04-01
PublicationDate_xml – month: 04
  year: 2009
  text: 2009-04-01
  day: 01
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Breast (Edinburgh)
PublicationTitleAlternate Breast
PublicationYear 2009
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Singletary (bib14) 2003; 10
Jeffrey, Birdwell, Ikeda (bib11) 1999; 134
Hayashi, Silver, van der Westhuizen (bib15) 2003; 185
Takayama, Sekine, Makuuchi (bib9) 2000; 356
Wada, Imoto, Yamauchi, Hasebe, Ochiai (bib19) 2006; 32
Rastogi, Anderson, Bear (bib6) 2008; 26
Burak, Angese, Povoslo (bib13) 2003; 98
Khatri, McGahan, Ramsamooj (bib17) 2007; 14
Dowlatshahi, Francescatti, Bloom (bib20) 2002; 184
Rutgers (bib4) 2008; 26
Lucci, Kelemen, Miller (bib3) 2001; 192
(bib5) 2005; 365
Buzdar, Valero, Ibrahim (bib7) 2007; 13
Noguchi, Earashi, Fujii (bib16) 2006; 93
Gianfelice, Khiat, Amara, Belblidia, Boulanger (bib22) 2003; 227
Fisher, Anderson, Bryant (bib1) 2002; 347
Sutherland, Williams, Padbury, Gotley, Stokes, Maddern (bib8) 2006; 141
Medina-Franco, Soto-Germes, Ulloa-Gomez (bib18) 2008; 15
Sabel, Kaufman, Whitworth (bib21) 2004; 11
Veronesi, Cascinelli, Mariani (bib2) 2002; 347
Goetz, Callstrom, Charboneau (bib10) 2004; 22
Izzo, Thomas, Delrio (bib12) 2001; 92
Goetz (10.1016/j.breast.2009.02.008_bib10) 2004; 22
Izzo (10.1016/j.breast.2009.02.008_bib12) 2001; 92
Takayama (10.1016/j.breast.2009.02.008_bib9) 2000; 356
Rutgers (10.1016/j.breast.2009.02.008_bib4) 2008; 26
Noguchi (10.1016/j.breast.2009.02.008_bib16) 2006; 93
Gianfelice (10.1016/j.breast.2009.02.008_bib22) 2003; 227
Sabel (10.1016/j.breast.2009.02.008_bib21) 2004; 11
Rastogi (10.1016/j.breast.2009.02.008_bib6) 2008; 26
Singletary (10.1016/j.breast.2009.02.008_bib14) 2003; 10
Buzdar (10.1016/j.breast.2009.02.008_bib7) 2007; 13
Medina-Franco (10.1016/j.breast.2009.02.008_bib18) 2008; 15
Veronesi (10.1016/j.breast.2009.02.008_bib2) 2002; 347
Lucci (10.1016/j.breast.2009.02.008_bib3) 2001; 192
Fisher (10.1016/j.breast.2009.02.008_bib1) 2002; 347
Hayashi (10.1016/j.breast.2009.02.008_bib15) 2003; 185
Sutherland (10.1016/j.breast.2009.02.008_bib8) 2006; 141
Wada (10.1016/j.breast.2009.02.008_bib19) 2006; 32
(10.1016/j.breast.2009.02.008_bib5) 2005; 365
Jeffrey (10.1016/j.breast.2009.02.008_bib11) 1999; 134
Burak (10.1016/j.breast.2009.02.008_bib13) 2003; 98
Khatri (10.1016/j.breast.2009.02.008_bib17) 2007; 14
Dowlatshahi (10.1016/j.breast.2009.02.008_bib20) 2002; 184
References_xml – volume: 13
  start-page: 228
  year: 2007
  end-page: 233
  ident: bib7
  article-title: Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen
  publication-title: Clin Cancer Res
– volume: 11
  start-page: 542
  year: 2004
  end-page: 549
  ident: bib21
  article-title: Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial
  publication-title: Ann Surg Oncol
– volume: 365
  start-page: 1687
  year: 2005
  end-page: 1717
  ident: bib5
  article-title: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  publication-title: Lancet
– volume: 185
  start-page: 429
  year: 2003
  end-page: 435
  ident: bib15
  article-title: Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation
  publication-title: Am J Surg
– volume: 356
  start-page: 802
  year: 2000
  end-page: 807
  ident: bib9
  article-title: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
  publication-title: Lancet
– volume: 92
  start-page: 2036
  year: 2001
  end-page: 2044
  ident: bib12
  article-title: Radiofrequency ablation in patients with primary breast carcinoma
  publication-title: Cancer
– volume: 93
  start-page: 120
  year: 2006
  end-page: 128
  ident: bib16
  article-title: Radiofrequency ablation of small breast cancer followed by surgical resection
  publication-title: J Surg Oncol
– volume: 347
  start-page: 1233
  year: 2002
  end-page: 1241
  ident: bib1
  article-title: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive ductal cancer
  publication-title: N Engl J Med
– volume: 26
  start-page: 698
  year: 2008
  end-page: 702
  ident: bib4
  article-title: Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases
  publication-title: J Clin Oncol
– volume: 26
  start-page: 778
  year: 2008
  end-page: 785
  ident: bib6
  article-title: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
  publication-title: J Clin Oncol
– volume: 15
  start-page: 1689
  year: 2008
  end-page: 1695
  ident: bib18
  article-title: Radiofrequency ablation of invasive breast carcinoma: A phase II trial
  publication-title: Ann Surg Oncol
– volume: 98
  start-page: 1369
  year: 2003
  end-page: 1376
  ident: bib13
  article-title: Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision
  publication-title: Cancer
– volume: 14
  start-page: 1644
  year: 2007
  end-page: 1652
  ident: bib17
  article-title: A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinoma: use of saline-cooled tip electrode
  publication-title: Ann Surg Oncol
– volume: 10
  start-page: 4
  year: 2003
  end-page: 9
  ident: bib14
  article-title: Feasibility of radiofrequency ablation for primary breast cancer
  publication-title: Breast Cancer
– volume: 192
  start-page: 453
  year: 2001
  end-page: 458
  ident: bib3
  article-title: National practice patterns of sentinel lymph node dissection for breast carcinoma
  publication-title: J Am Coll Surg
– volume: 227
  start-page: 849
  year: 2003
  end-page: 855
  ident: bib22
  article-title: MR imaging-guided focused US ablation of breast cancer: histopathological assessment of effectiveness—initial experience
  publication-title: Radiology
– volume: 22
  start-page: 300
  year: 2004
  end-page: 306
  ident: bib10
  article-title: Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study
  publication-title: J Clin Oncol
– volume: 184
  start-page: 3559
  year: 2002
  end-page: 3563
  ident: bib20
  article-title: Laser therapy for small breast cancers
  publication-title: Am J Surg
– volume: 141
  start-page: 181
  year: 2006
  end-page: 190
  ident: bib8
  article-title: Radiofrequency ablation of liver tumors: a systematic review
  publication-title: Arch Surg
– volume: 347
  start-page: 1227
  year: 2002
  end-page: 1232
  ident: bib2
  article-title: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer
  publication-title: N Engl J Med
– volume: 134
  start-page: 1064
  year: 1999
  end-page: 1068
  ident: bib11
  article-title: Radiofrequency ablation of breast cancer
  publication-title: Arch Surg
– volume: 32
  start-page: 29
  year: 2006
  end-page: 33
  ident: bib19
  article-title: Predictors of tumor involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel node
  publication-title: Eur J Surg Oncol
– volume: 347
  start-page: 1233
  year: 2002
  ident: 10.1016/j.breast.2009.02.008_bib1
  article-title: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive ductal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa022152
– volume: 93
  start-page: 120
  year: 2006
  ident: 10.1016/j.breast.2009.02.008_bib16
  article-title: Radiofrequency ablation of small breast cancer followed by surgical resection
  publication-title: J Surg Oncol
  doi: 10.1002/jso.20398
– volume: 13
  start-page: 228
  year: 2007
  ident: 10.1016/j.breast.2009.02.008_bib7
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-1345
– volume: 184
  start-page: 3559
  year: 2002
  ident: 10.1016/j.breast.2009.02.008_bib20
  article-title: Laser therapy for small breast cancers
  publication-title: Am J Surg
  doi: 10.1016/S0002-9610(02)00942-X
– volume: 141
  start-page: 181
  year: 2006
  ident: 10.1016/j.breast.2009.02.008_bib8
  article-title: Radiofrequency ablation of liver tumors: a systematic review
  publication-title: Arch Surg
  doi: 10.1001/archsurg.141.2.181
– volume: 15
  start-page: 1689
  year: 2008
  ident: 10.1016/j.breast.2009.02.008_bib18
  article-title: Radiofrequency ablation of invasive breast carcinoma: A phase II trial
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-008-9875-4
– volume: 92
  start-page: 2036
  year: 2001
  ident: 10.1016/j.breast.2009.02.008_bib12
  article-title: Radiofrequency ablation in patients with primary breast carcinoma
  publication-title: Cancer
  doi: 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W
– volume: 11
  start-page: 542
  year: 2004
  ident: 10.1016/j.breast.2009.02.008_bib21
  article-title: Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial
  publication-title: Ann Surg Oncol
  doi: 10.1245/ASO.2004.08.003
– volume: 22
  start-page: 300
  year: 2004
  ident: 10.1016/j.breast.2009.02.008_bib10
  article-title: Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.03.097
– volume: 14
  start-page: 1644
  year: 2007
  ident: 10.1016/j.breast.2009.02.008_bib17
  article-title: A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinoma: use of saline-cooled tip electrode
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-006-9315-2
– volume: 134
  start-page: 1064
  year: 1999
  ident: 10.1016/j.breast.2009.02.008_bib11
  article-title: Radiofrequency ablation of breast cancer
  publication-title: Arch Surg
  doi: 10.1001/archsurg.134.10.1064
– volume: 227
  start-page: 849
  year: 2003
  ident: 10.1016/j.breast.2009.02.008_bib22
  article-title: MR imaging-guided focused US ablation of breast cancer: histopathological assessment of effectiveness—initial experience
  publication-title: Radiology
  doi: 10.1148/radiol.2281012163
– volume: 192
  start-page: 453
  year: 2001
  ident: 10.1016/j.breast.2009.02.008_bib3
  article-title: National practice patterns of sentinel lymph node dissection for breast carcinoma
  publication-title: J Am Coll Surg
  doi: 10.1016/S1072-7515(01)00798-0
– volume: 26
  start-page: 778
  year: 2008
  ident: 10.1016/j.breast.2009.02.008_bib6
  article-title: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.15.0235
– volume: 10
  start-page: 4
  year: 2003
  ident: 10.1016/j.breast.2009.02.008_bib14
  article-title: Feasibility of radiofrequency ablation for primary breast cancer
  publication-title: Breast Cancer
  doi: 10.1007/BF02967618
– volume: 185
  start-page: 429
  year: 2003
  ident: 10.1016/j.breast.2009.02.008_bib15
  article-title: Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation
  publication-title: Am J Surg
  doi: 10.1016/S0002-9610(03)00061-8
– volume: 32
  start-page: 29
  year: 2006
  ident: 10.1016/j.breast.2009.02.008_bib19
  article-title: Predictors of tumor involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel node
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2005.08.010
– volume: 365
  start-page: 1687
  year: 2005
  ident: 10.1016/j.breast.2009.02.008_bib5
  article-title: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66544-0
– volume: 347
  start-page: 1227
  year: 2002
  ident: 10.1016/j.breast.2009.02.008_bib2
  article-title: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020989
– volume: 26
  start-page: 698
  year: 2008
  ident: 10.1016/j.breast.2009.02.008_bib4
  article-title: Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.14.4667
– volume: 356
  start-page: 802
  year: 2000
  ident: 10.1016/j.breast.2009.02.008_bib9
  article-title: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)02654-4
– volume: 98
  start-page: 1369
  year: 2003
  ident: 10.1016/j.breast.2009.02.008_bib13
  article-title: Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision
  publication-title: Cancer
  doi: 10.1002/cncr.11642
SSID ssj0009368
Score 2.052607
Snippet To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation (RFA) for...
Abstract To evaluate the safety and reliability of thermal ablation therapy instead of breast-conserving surgery (BCS), we performed radiofrequency ablation...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 130
SubjectTerms Adult
Breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Breast-conserving surgery
Catheter Ablation
Combined Modality Therapy
Feasibility Studies
Female
Hematology, Oncology and Palliative Medicine
Humans
Intraductal components
Mastectomy, Segmental
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Radiofrequency ablation
Reproducibility of Results
Sentinel Lymph Node Biopsy
Treatment Outcome
Title Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0960977609000320
https://www.clinicalkey.es/playcontent/1-s2.0-S0960977609000320
https://dx.doi.org/10.1016/j.breast.2009.02.008
https://www.ncbi.nlm.nih.gov/pubmed/19324550
https://www.proquest.com/docview/67152159
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQSBUXVGgLC5T6wDXdrO2skyNCoIUVHFpQuVl-Slt1k1WyqNoLv52ZxIFWLaLqJZESvz2e-WzPg5BjxkNhQxaSYCxsUAx3SeEkhnuxZiQkSASHRwNX1-PJrbi8y-7WyGlvC4NqlZH3dzy95dbxyzCO5nAxmw2_ts7SpIQHAnuG-3YhJNL654dnNY-Ct-ZwmDjB1L35XKvjZVDxexm9VqLnzvwl8fQS_GzF0PlbshXxIz3pmrhN1ny5Q95cxRvyd6QETBc1Xle09R1Lq5LW2s2qUHdq0yuqTacBRwNQQfXTO2pWdIHdhqLn0FY8yp-v4HcNZQDHoRe06wS1SCU1je5Ym_fk9vzs5nSSxJgKic24WCaeSZbl3DMEDiINQWivc2YA1jjpGPqGcd6KLNgwNhiYWJgit9oZa2WaB8c_kPWyKv0eoZJZzrXnxmiAYV4XwQB-cCzTUhqdpgPC-6FUNjocx7gXP1SvWfZddW3HWJiFSpmCCRiQ5CnXonO48Ur6rJ8l1RuTAvtTIBFeySf_ls83cQ03aqQaSKn-oLNfc_5Gqv9Q56eejBSsYrya0aWv7hs1loijsmJAdjvqeu47AGy0PN__71oPyGZ_BZaODsn6sr73HwFJLc1Ru1SOyMbJxXRyje_pl2_TRxTjISg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLeqIQEXBGyw8lUfuGZN7bhOjmhiaqHthU3azfKnVMSSKumEetnfvvcSh4LGNMQlh8R2_PH8_LP9e-8R8pHxUNggQhKMhQ2K4S4pnMRwL9ZMMgkrgsOjgeVqOrvIvlyKywE57W1hkFYZdX-n01ttHd-MY2-ON-v1-FvrLE1KeCCwZ7Bvf5QJLpHXd3Kz53kUvLWHw9QJJu_t51qSl0Hm9za6rUTXnfl969N9-LNdh86ek2cRQNJPXR1fkIEvX5LHy3hFfkhKAHWR8rqjrfNYWpW01m5dhbrjTe-oNh0FjgYQg-qnd9Ts6AbbDUVfQV3xLP9qB59rKANUDp3TrhHUopjUNPpjbY7Ixdnn89NZEoMqJFbwbJt4JpnIuWeIHLI0hEx7nTMDuMZJx9A5jPM2E8GGqcHIxJkpcqudsVameXD8FTkoq9IfEyqZ5Vx7bowGHOZ1EQwACMeEltLoNB0S3nelstHjOAa--KF6atl31dUdg2EWKmUKBmBIkl-5Np3HjQfSi36UVG9NCvpPwZLwQD75t3y-iZO4URPVQEp1R9B-z_mHrP7DP0e9GCmYxng3o0tfXTdqKhFIiWJIXnfStW87IGw0PX_z338dkSez8-VCLearr2_J0_4-LJ28Iwfb-tq_B1i1NR_aaXMLfT4hGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+study+on+radiofrequency+ablation+followed+by+partial+mastectomy+for+stage+I+breast+cancer+patients&rft.jtitle=Breast+%28Edinburgh%29&rft.au=Imoto%2C+Shigeru&rft.au=Wada%2C+Noriaki&rft.au=Sakemura%2C+Noriko&rft.au=Hasebe%2C+Takahiro&rft.date=2009-04-01&rft.pub=Elsevier+Ltd&rft.issn=0960-9776&rft.eissn=1532-3080&rft.volume=18&rft.issue=2&rft.spage=130&rft.epage=134&rft_id=info:doi/10.1016%2Fj.breast.2009.02.008&rft.externalDocID=S0960977609000320
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09609776%2FS0960977609X00032%2Fcov150h.gif